Orthofix International | OFIX - Selling And Administration Expenses


Orthofix International reported $112.21M in Selling and Administration Expenses for its fiscal quarter ending in September of 2024.





Selling And Administration Expenses Change Date
Accuray USD 127.32M 500.16M Sep/2025
AngioDynamics USD 35.99M 14K Feb/2025
Artivion USD 50.02M 697K Sep/2024
AtriCure USD 78.34M 109K Dec/2025
Dexcom USD 299.9M 31.5M Dec/2025
EDAP TMS EUR 8.81M 1.57M Sep/2025
Globus Medical USD 318.48M 4.88M Dec/2025
Hologic USD 2.5B 2.24B Dec/2025
Inogen USD 43.77M 510K Jun/2024
Insulet USD 331.4M 16.2M Dec/2025
Integra LifeSciences USD 156.45M 12.6M Dec/2025
J&J USD 6.75B 831M Dec/2025
Medtronic 2.97B 159M Sep/2025
Mesa Laboratories USD 27.31M 380K Sep/2024
Orthofix International USD 112.21M 1.1M Sep/2024
Smith & Nephew USD 1.42B 65M Dec/2025
STAAR Surgical USD 38.94M 20.44M Dec/2025
Stryker USD 2.14B 150M Dec/2025
Surmodics USD 14.58M 2.05M Sep/2024
Tandem Diabetes Care USD 99.86M 5.34M Dec/2025
Teleflex USD 222.37M 59.4M Dec/2025
Veracyte USD 43.31M 8.43M Dec/2025
Zimmer Biomet Holdings USD 855.7M 44.3M Dec/2025